Stay updated on AMG 820 and Pembrolizumab Combo in Solid Tumor Clinical Trial

Sign up to get notified when there's something new on the AMG 820 and Pembrolizumab Combo in Solid Tumor Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AMG 820 and Pembrolizumab Combo in Solid Tumor Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision: v3.4.1 is now displayed, replacing the previous v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-05T14:25:01.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    Added a Show glossary option and updated non-critical metadata labels (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0), which do not alter the core study details or user actions.
    Difference
    0.2%
    Check dated 2026-01-29T07:34:11.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision tag updated from v3.3.3 to v3.3.4 on the page.
    Difference
    0.0%
    Check dated 2026-01-15T03:06:33.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Updated the study locations: new sites added across multiple US states (Georgia, Massachusetts, Michigan, New York, Pennsylvania, South Carolina, Texas) and international regions (New South Wales, Victoria, Ontario); some existing location entries were removed as part of a v3.3.3 update.
    Difference
    1.0%
    Check dated 2025-12-24T15:00:17.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.3.2, replacing the previous Revision: v3.2.0.
    Difference
    0.0%
    Check dated 2025-11-25T14:42:24.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    The funding/status notice about government operations has been removed from the page; the rest of the study details and site links remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-18T07:25:13.000Z thumbnail image

Stay in the know with updates to AMG 820 and Pembrolizumab Combo in Solid Tumor Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AMG 820 and Pembrolizumab Combo in Solid Tumor Clinical Trial page.